Technology
In vivo AI CRO
C. elegans: Unique Model for High-Throughput Bio-Data Generation
Automated Preclinical CRO Platform Utilizing C. elegans
In vivo automated equipment
Microfluidic Kit for Multidimensional
Physiological Data Measurement
Physiological Data Measurement
AI analytics SaaS
In vivo AI CRO
Bridging the Missing Link between Traditional CROs and AI-Driven Drug Discovery
Traditional CRO
Time to Completion
1Y
4.5Y
in vivo data
5,000
50
Microbiome
35.3% CAGR:
The Surging Microbiome Therapeutics Market
* Grand View Research
FDA-approved product
Rebyota, Vowst entering the market
bacterial/protein-based DDS
for stability & regulatory advantages
gut-brain immune axis
for CNS/inflammatory diseases
FDA-approved product
Rebyota, Vowst entering the market
bacterial/protein-based DDS
for stability & regulatory advantages
gut-brain immune axis
for CNS/inflammatory diseases
Microbiome
Microbiome Therapeutics Targeting Gut–Brain Axis
Microbiome
Gut-Brain Axis-Based Microbiome Engineering for Neurodegenerative Disorders and Parkinson’s Disease Inhibition
Indications
Platform Type
Development Stage
Parkinson’s, Alzheimer’s, Obesity
Spore-derived protein-based DDS + AI–C. elegans
Functional food launched, IND in preparation
Nanocomplex
The $17.7 Billion Global Nano-Cosmetics Opportunity
* The Business Resarch Company
The global nano-cosmetics market is surging toward a $17.7 billion (approx. 20 trillion KRW) valuation by 2029, reflecting a robust 16.2% CAGR.
The global nano-cosmetics market is surging toward a $17.7 billion (approx. 20 trillion KRW) valuation by 2029, reflecting a robust 16.2% CAGR.
Nanocomplex
Nano-Formulation of Proprietary Strains and Product Diversification
- Our proprietary platform engineers bio-macromolecules, including proteins, into high-performance nanomaterials optimized for both oral and topical delivery systems.
- This versatile technology enables a broad range of high-value applications, from neuro-supportive nutraceuticals targeting dopamine depletion to advanced therapeutic and cosmeceutical solutions for anti-aging and specialized skin-trouble care.
- This versatile technology enables a broad range of high-value applications, from neuro-supportive nutraceuticals targeting dopamine depletion to advanced therapeutic and cosmeceutical solutions for anti-aging and specialized skin-trouble care.
Nanocomplex
Precision Manufacturing of Oral Biologic Nanocarriers
* Biotechnology and Bioprocess Engineering 26: 40-50 (2021) DOI 10.1007/s12257-021-0243-6
Precision manufacturing of high-performance nanocarriers designed to prevent GI degradation and facilitate systemic absorption of biologics via the small intestine.
Precision manufacturing of high-performance nanocarriers designed to prevent GI degradation and facilitate systemic absorption of biologics via the small intestine.
Nanocomplex
Targeted Oral Delivery & Systemic Absorption Mechanism
* https://pubs.acs.org/doi/10.1021/acsami.3c11756
* ACS Applied Materials & Interfaces, 15, 44, 50889–50897 (2023).
Facilitates targeted release in the small intestine by bypassing gastric acidity. Prevents enzymatic breakdown to maximize systemic absorption of biologics, as validated through in vivo efficacy studies.
* ACS Applied Materials & Interfaces, 15, 44, 50889–50897 (2023).
Facilitates targeted release in the small intestine by bypassing gastric acidity. Prevents enzymatic breakdown to maximize systemic absorption of biologics, as validated through in vivo efficacy studies.
Get a 1:1 consultation with elegslab today.
Contact us, and we’ll get back to you within 3 business days.